|1.||Sato, Yuhki: 2 articles (11/2005 - 04/2004)|
|2.||Itoh, Hiroki: 2 articles (11/2005 - 04/2004)|
|3.||Takeyama, Masaharu: 2 articles (11/2005 - 04/2004)|
|4.||Katagiri, Fumihiko: 2 articles (11/2005 - 04/2004)|
|5.||Naito, Yuji: 1 article (06/2010)|
|6.||Yoshikawa, Toshikazu: 1 article (06/2010)|
|7.||Arakawa, T: 1 article (02/2007)|
|8.||Oshitani, N: 1 article (02/2007)|
|9.||Tanigawa, T: 1 article (02/2007)|
|10.||Shiba, M: 1 article (02/2007)|
01/01/1984 - "Cetraxate was effective in preventing only stress-induced ulcers and had almost no effect on other experimental ulcers. "
05/01/1985 - "[Pharmacokinetic and pharmacological studies on cetraxate, an anti-ulcer agent]."
12/01/1979 - "Studies on the mechanism of action of cetraxate [4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride], a new anti-ulcer agent."
02/01/2007 - "In conclusion, the superiority of cetraxate over placebo and non-inferiority to cetraxate for 7 drugs was established in the respect of effect on ulcer healing."
04/01/2004 - "Cetraxate hydrochloride (cetraxate), an anti-ulcer drug, produces a dose-related increase in mucosal blood flow. "
01/01/1983 - "From these results, it appeared that cetraxate is effective against acute gastritis and acute aggravation of chronic gastritis."
11/01/1990 - "These findings in the cetraxate hydrochloride group are recognized to be an aggravation of chronic gastritis. "
01/01/1983 - "Therapeutic effects of cetraxate against acute gastritis and acute aggravation of chronic gastritis. "
01/01/1983 - "To determine the efficacy of cetraxate against acute gastritis and acute aggravation of chronic gastritis, a comparison was made with aldioxa as the standard drug by the double-blind method based mainly on observations by gastroscopy. "
08/15/2004 - "To determine the efficacy and safety of DA-9601 on erosive gastritis versus cetraxate as a standard drug by gastrointestinal endoscopy. "
09/01/1987 - "The effect of cetraxate hydrochloride (Neuer) on the induction of intestinal metaplasia by intragastric instillation of 5% NaOH solution was investigated in Wistar rats. "
09/01/1987 - "Inhibitory effect of prolonged oral administration of cetraxate hydrochloride on experimentally-induced intestinal metaplasia in Wistar rats."
09/01/1987 - "Oral administration of cetraxate, beginning 2 days after NaOH treatment, resulted in a significant increase in antral mucosal blood flow and a significant reduction in the incidence and amount of intestinal metaplasia in experimental week 25, but no significant changes in basal acid secretion or antral mucosal pH. On histological examination, goblet cell metaplasia were frequently seen. "
|4.||Stomach Ulcer (Gastric Ulcer)
02/01/2007 - "In the comparative trial of cetraxate vs. placebo, the healing rate of gastric ulcer at 8-week endoscopy in the cetraxate was significantly higher than that in the placebo groups (88.6% and 62.2%, p = 0.0062). "
01/01/1993 - "Endothelin-1-induced gastric ulcer is attenuated by cetraxate."
04/01/1989 - "Cetraxate showed antiulcer activity against a part of the OPC-12759-positive gastric ulcer models. "
07/01/1985 - "Cetraxate and antacid in the treatment of gastric ulcer. "
01/01/1979 - "Therapeutic effect of cetraxate on gastric ulcers (Phase I)."
|5.||Duodenal Ulcer (Curling's Ulcer)
|3.||Tranexamic Acid (AMCA)
|5.||Aspirin (Acetylsalicylic Acid)
|6.||Nitric Oxide Synthase (NO Synthase)
|8.||Epidermal Growth Factor (EGF)
|9.||Acetic Acid (Vinegar)